S

Structure Therapeutics Inc
NASDAQ:GPCR

Watchlist Manager
Structure Therapeutics Inc
NASDAQ:GPCR
Watchlist
Price: 91.02 USD 2.69%
Market Cap: 5.5B USD

Profitability Summary

Structure Therapeutics Inc's profitability score is 25/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

25/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

25/100
Profitability
Score
25/100
Profitability
Score

Margins

Earnings Waterfall
Structure Therapeutics Inc

Margins Comparison
Structure Therapeutics Inc Competitors

Country Company Market Cap Operating
Margin
Net
Margin
US
Structure Therapeutics Inc
NASDAQ:GPCR
5.5B USD
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
984.9B USD
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
525.1B USD
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
273.5B CHF
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
207.4B GBP
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
219.1B CHF
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
272.2B USD
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
145.1B USD
Loading...
Loading...
No Stocks Found

Return on Capital

Return on Capital Comparison
Structure Therapeutics Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Structure Therapeutics Inc
NASDAQ:GPCR
5.5B USD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
984.9B USD
Loading...
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
525.1B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
273.5B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
207.4B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
219.1B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
272.2B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
145.1B USD
Loading...
Loading...
Loading...
Loading...
No Stocks Found

Free Cash Flow

Free Cash Flow Analysis
Structure Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate